KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates New York, NY, October 15, 2024 – PRISM
PITTSBURGH, PA, October 15, 2024 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing therapies for serious diseases
NEW YORK, October 14, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of
PITTSBURGH, Oct. 09, 2024 – PRISM MediaWire – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious
London, October 5, 2024 – PRISM MediaWire – We are pleased to share an exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy,
London, October 5, 2024 – PRISM MediaWire – Temos o prazer de compartilhar uma entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia,
Londres, October 5, 2024 – PRISM MediaWire – Nos complace compartir una entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación
IRVINE, Calif., Oct. 02, 2024 – PRISM MediaWire – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that its
Strategic head-to-head study of BR-AC vs. standard of care aims to demonstrate healing superiority potential to support increased payor coverage and market growth The study
NEWPORT BEACH, CA, October 2, 2024 – PRISM MediaWire – Neon Bloom, Inc. (OTC PINK: NBCO)announced today that it has finalized a business relationship with
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
